Beyond Meat’s Newest Expansion Into China

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Beyond Meat’s Newest Expansion Into China

© AsiaVision / E+ via Getty Images

Beyond Meat Inc. (NASDAQ: BYND) has announced that it will further expand into China with the grand opening of its manufacturing facility in the Jiaxing Economic & Technological Development Zone near Shanghai. This facility is intended to pave the way for Beyond Meat to efficiently scale up to meet future needs and demand.

This move comes just one year after the company first entered mainland China through a nationwide partnership with Starbucks China. Within its first year in the market, Beyond Meat has expanded menu offerings at Starbucks China and has partnered with well-known foodservice and retail brands.

Note that this is Beyond Meat’s first end-to-end manufacturing facility outside the United States.

The facility will produce Beyond Meat’s plant-based pork, beef and poultry products, including Beyond Pork, the company’s first innovation created specifically for the Chinese market. By producing closer to the consumer and leveraging local supply chains, the company is investing in the growth of the plant-based meat category in China, and the facility underscores the company’s commitment to China as a region for long-term growth.

[nativounit]

Apart from the scaled production that will support expanding retail and foodservice business within China, the facility will also feature research and development capabilities to create unique product offerings and support Beyond Meat’s local strategic partners.

This new Chinese plant is expected to significantly increase the speed and scale in which Beyond Meat can produce and distribute its products within the region while also improving the company’s cost structure and sustainability of operations.

Beyond Meat stock traded about 1% to $135.38 on Wednesday, in a 52-week range of $67.39 to $221.00. The consensus price target is $128.80.

[recirclink id=859712][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618